Chicago, IL, United States of America

Berry S Mellovitz

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Berry S Mellovitz. Retrieved from https://idiyas.com/inventor/berry-s-mellovitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Berry S Mellovitz

Introduction

Berry S Mellovitz is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Berry S Mellovitz holds a patent for "DNA encoding human erythropoietin analog." This invention represents a crucial advancement in the production of erythropoietin, a hormone that plays a vital role in red blood cell production. The patent highlights his expertise in genetic engineering and its applications in medicine. He has 1 patent to his name.

Career Highlights

Mellovitz is currently employed at Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His career reflects a commitment to advancing medical science through innovative solutions.

Collaborations

Throughout his career, Berry has collaborated with esteemed colleagues, including Gregory F Okasinski and Peter J DeVries. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Berry S Mellovitz exemplifies the spirit of innovation in the biotechnology sector. His contributions, particularly in the field of erythropoietin analogs, demonstrate the impact of dedicated inventors on healthcare advancements. His work continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…